In situ forming hydrogels based on chitosan for drug delivery and tissue regeneration

Asian Journal of Pharmaceutical Sciences

Volumn 11, Issue 6, 2016, Pages 673-683

  Liu, Li ^a   Gao, Qi ^a   Lu, Xuemin ^a   Zhou, Huifang ^b  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Chitosan; Drug delivery; In situ gel; Sol gel transition; Tissue regeneration

Indexed keywords

CHITOSAN;

COVALENT BOND; CROSS LINKING; DRUG DELIVERY SYSTEM; DRUG IMPLANT; GELATION; HEAT SENSITIVITY; HUMAN; HYDROGEL; INTRANASAL DRUG ADMINISTRATION; INTRAOCULAR DRUG ADMINISTRATION; NONHUMAN; PH; PHASE SEPARATION; REVIEW; STATIC ELECTRICITY; TISSUE ENGINEERING; TISSUE REGENERATION; TISSUE SCAFFOLD; WOUND DRESSING; WOUND HEALING;

EID: 84996878193     PISSN: 18180876     EISSN: 2221285X     Source Type: Journal    
DOI: 10.1016/j.ajps.2016.07.001     Document Type: Review

References (86)

1. [1] Kishida, A., Ikada, Y., Hydrogels for biomedical and pharmaceutical applications. Dumitriu, S., (eds.) Polymeric biomaterials, 2nd ed, 2001, CRC Press, 113 Revised and Expanded ed.
2. [2] Fakhari, A., Subramony, J.A., Engineered in-situ depot-forming hydrogels for intratumoral drug delivery. J Control Release 220 (2015), 465–475.
3. [3] Kempe, S., Mader, K., In situ forming implants – an attractive formulation principle for parenteral depot formulations. J Control Release 161 (2012), 668–679.
4. [4] Almeida, H., Amaral, M.H., Lobao, P., et al. In situ gelling systems: a strategy to improve the bioavailability of ophthalmic pharmaceutical formulations. Drug Discov Today 19 (2014), 400–412.
5. [5] Wang, X.Q., Liu, G.Y., Ma, J.L., et al. In situ gel-forming system: an attractive alternative for nasal drug delivery. Crit Rev Ther Drug Carrier Syst 30 (2013), 411–434.
6. [6] Russo, T., Tunesi, M., Giordano, C., et al. Hydrogels for central nervous system therapeutic strategies. Proc Inst Mech Eng H 229 (2015), 905–916.
7. [7] Duceppe, N., Tabrizian, M., Advances in using chitosan-based nanoparticles for in vitro and in vivo drug and gene delivery. Expert Opin Drug Deliv 7 (2010), 1191–1207.
8. [8] Riva, R., Ragelle, H., des Rieux, A., et al. Chitosan and chitosan derivatives in drug delivery and tissue engineering. Jayakumar, R., Prabaharan, M., Muzzarelli, R.A.A., (eds.) Chitosan for biomaterials II, 2011, Springer-Verlag Berlin, Berlin, 19–44.
9. [9] Sezer, A.D., Cevher, E., Topical drug delivery using chitosan nano- and microparticles. Expert Opin Drug Deliv 9 (2012), 1129–1146.
10. [10] Teixeira, L.S., Feijen, J., van Blitterswijk, C.A., et al. Enzyme-catalyzed crosslinkable hydrogels: emerging strategies for tissue engineering. Biomaterials 33 (2012), 1281–1290.
11. [11] Gandhi, A., Paul, A., Sen, S.O., et al. Studies on thermoresponsive polymers: phase behaviour, drug delivery and biomedical applications. Asian J Pharm Sci 10 (2015), 99–107.
12. [12] Matanovic, M.R., Kristl, J., Grabnar, P.A., Thermoresponsive polymers: insights into decisive hydrogel characteristics, mechanisms of gelation, and promising biomedical applications. Int J Pharm 472 (2014), 262–275.
13. [13] Jeong, B., Bae, Y.H., Lee, D.S., et al. Biodegradable block copolymers as injectable drug-delivery systems. Nature 388 (1997), 860–862.
14. [14] Lee, J.Y., Kim, K.S., Kang, Y.M., et al. In vivo efficacy of paclitaxel-loaded injectable in situ-forming gel against subcutaneous tumor growth. Int J Pharm 392 (2010), 51–56.
15. [15] Jeong, B., Kibbey, M.R., Birnbaum, J.C., et al. Thermogelling biodegradable polymers with hydrophilic backbones: PEG-g-PLGA. Macromolecules 33 (2000), 8317–8322.
16. [16] Loh, X.J., Li, J., Biodegradable thermosensitive copolymer hydrogels for drug delivery. Expert Opin Ther Pat 17 (2007), 965–977.
17. [17] Teixeira, L.S.M., Feijen, J., van Blitterswijk, C.A., et al. Enzyme-catalyzed crosslinkable hydrogels: emerging strategies for tissue engineering. Biomaterials 33 (2012), 1281–1290.
18. [18] Songkroh, T., Xie, H.G., Yu, W.T., et al. In situ forming chitosan-based hydrogel as a lung sealant for biological lung volume reduction. Sci Bull 60 (2015), 235–240.
19. [19] Songkroh, T., Xie, H.G., Yu, W.T., et al. Injectable in situ forming chitosan-based hydrogels for curcumin delivery. Macromol Res 23 (2015), 53–59.
20. [20] Muzzarelli, R.A.A., Genipin-crosslinked chitosan hydrogels as biomedical and pharmaceutical aids. Carbohydr Polym 77 (2009), 1–9.
21. [21] Jalani, G., Rosenzweig, D.H., Makhoul, G., et al. Tough, in-situ thermogelling, injectable hydrogels for biomedical applications. Macromol Biosci 15 (2015), 473–480.
22. [22] Xu, X., Weng, Y.H., Xu, L., et al. Sustained release of Avastin (R) from polysaccharides cross-linked hydrogels forocular drug delivery. Int J Biol Macromol 60 (2013), 272–276.
23. [23] Li, X.Y., Weng, Y.H., Kong, X.Y., et al. A covalently crosslinked polysaccharide hydrogel for potential applications in drug delivery and tissue engineering. J Mater Sci Mater Med 23 (2012), 2857–2865.
24. [24] Fan, L.H., Tan, C., Wang, L.B., et al. Preparation, characterization and the effect of carboxymethylated chitosan-cellulose derivatives hydrogels on wound healing. J Appl Polym Sci 128 (2013), 2789–2796.
25. [25] Li, J., Hu, W.Q., Zhang, Y.J., et al. pH and glucose dually responsive injectable hydrogel prepared by in situ crosslinking of phenylboronic modified chitosan and oxidized dextran. J Polym Sci A Pol Chem 53 (2015), 1235–1244.
26. [26] Jo, S., Kim, S., Cho, T.H., et al. Effects of recombinant human bone morphogenic protein-2 and human bone marrow-derived stromal cells on in vivo bone regeneration of chitosan-poly(ethylene oxide) hydrogel. J Biomed Mater Res A 101 (2013), 892–901.
27. [27] Chen, C., Wang, L., Deng, L.D., et al. Performance optimization of injectable chitosan hydrogel by combining physical and chemical triple crosslinking structure. J Biomed Mater Res A 101 (2013), 684–693.
28. [28] Fan, M., Ma, Y., Mao, J.H., et al. Cytocompatible in situ forming chitosan/hyaluronan hydrogels via a metal-free click chemistry for soft tissue engineering. Acta Biomater 20 (2015), 60–68.
29. [29] Hintzen, F., Laffleur, F., Sarti, F., et al. Thiomers: influence of molar mass on in situ gelling properties. Int J Pharm 436 (2012), 120–126.
30. [30] Amoozgar, Z., Rickett, T., Park, J., et al. Semi-interpenetrating network of polyethylene glycol and photocrosslinkable chitosan as an in-situ-forming nerve adhesive. Acta Biomater 8 (2012), 1849–1858.
31. [31] Hu, J.L., Hou, Y.P., Park, H., et al. Visible light crosslinkable chitosan hydrogels for tissue engineering. Acta Biomater 8 (2012), 1730–1738.
32. [32] Chenite, A., Chaput, C., Wang, D., et al. Novel injectable neutral solutions of chitosan form biodegradable gels in situ. Biomaterials 21 (2000), 2155–2161.
33. [33] Zhou, H.Y., Jiang, L.J., Cao, P.P., et al. Glycerophosphate-based chitosan thermosensitive hydrogels and their biomedical applications. Carbohydr Polym 117 (2015), 524–536.
34. [34] Supper, S., Anton, N., Seidel, N., et al. Thermosensitive chitosan/glycerophosphate-based hydrogel and its derivatives in pharmaceutical and biomedical applications. Expert Opin Drug Deliv 11 (2014), 249–267.
35. [35] Supper, S., Anton, N., Seidel, N., et al. Rheological study of chitosan/polyol-phosphate systems: influence of the polyol part on the thermo-induced gelation mechanism. Langmuir 29 (2013), 10229–10237.
36. [36] Dang, Q.F., Yan, J.Q., Lin, H., et al. Biological evaluation of chitosan-based in situ-forming hydrogel with low phase transition temperature. J Appl Polym Sci, 132, 2015.
37. [37] Naik, A., Nair, H., Formulation and evaluation of thermosensitive biogels for nose to brain delivery of doxepin. Biomed Res Int, 2014, 2014, 847547.
38. [38] Supper, S., Anton, N., Boisclair, J., et al. Chitosan/glucose 1-phosphate as new stable in situ forming depot system for controlled drug delivery. Eur J Pharm Biopharm 88 (2014), 361–373.
39. [39] Shirosaki, Y., Hirai, M., Hayakawa, S., et al. Preparation and in vitro cytocompatibility of chitosan-siloxane hybrid hydrogels. J Biomed Mater Res A 103 (2015), 289–299.
40. [40] Naderi-Meshkin, H., Andreas, K., Matin, M.M., et al. Chitosan-based injectable hydrogel as a promising in situ forming scaffold for cartilage tissue engineering. Cell Biol Int 38 (2014), 72–84.
41. [41] Hoemann, C.D., Chenite, A., Sun, J., et al. Cytocompatible gel formation of chitosan-glycerol phosphate solutions supplemented with hydroxyl ethyl cellulose is due to the presence of glyoxal. J Biomed Mater Res A 83A (2007), 521–529.
42. [42] Liu, X.J., Chen, Y., Huang, Q.L., et al. A novel thermo-sensitive hydrogel based on thiolated chitosan/hydroxyapatite/beta-glycerophosphate. Carbohydr Polym 110 (2014), 62–69.
43. [43] Dashtimoghadam, E., Mirzadeh, H., Taromi, F.A., et al. Thermoresponsive biopolymer hydrogels with tunable gel characteristics. RSC Adv 4 (2014), 39386–39393.
44. [44] Li, C., Hou, J.X., Gu, J.J., et al. Synthesis and thermal gelation of hydroxypropyl chitin. RSC Adv 5 (2015), 39677–39685.
45. [45] Li, Z.Z., Cho, S., Kwon, I.C., et al. Preparation and characterization of glycol chitin as a new thermogelling polymer for biomedical applications. Carbohydr Polym 92 (2013), 2267–2275.
46. [46] Bhattarai, N., Matsen, F.A., Zhang, M., PEG-grafted chitosan as an injectable thermoreversible hydrogel. Macromol Biosci 5 (2005), 107–111.
47. [47] Kang, E.Y., Moon, H.J., Joo, M.K., et al. Thermogelling chitosan-g-(PAF-PEG) aqueous solution as an injectable scaffold. Biomacromolecules 13 (2012), 1750–1757.
48. [48] Liu, L., Tang, X., Wang, Y., et al. Smart gelation of chitosan solution in the presence of NaHCO3 for injectable drug delivery system. Int J Pharm 414 (2011), 6–15.
49. [49] Li, F.F., Liu, Y., Ding, Y., et al. A new injectable in situ forming hydroxyapatite and thermosensitive chitosan gel promoted by Na2CO3. Soft Matter 10 (2014), 2292–2303.
50. [50] Mekhail, M., Daoud, J., Almazan, G., et al. Rapid, guanosine 5’-diphosphate-induced, gelation of chitosan sponges as novel injectable scaffolds for soft tissue engineering and drug delivery applications. Adv Healthc Mater 2 (2013), 1126–1130.
51. [51] Mekhail, M., Almazan, G., Tabrizian, M., Purine-crosslinked injectable chitosan sponges promote oligodendrocyte progenitor cells’ attachment and differentiation. Biomater Sci 3 (2015), 279–287.
52. [52] Abueva, C.D.G., Padalhin, A.R., Min, Y.K., et al. Preformed chitosan cryogel-biphasic calcium phosphate: a potential injectable biocomposite for pathologic fracture. J Biomater Appl 30 (2015), 182–192.
53. [53] Zhang, J., Wang, Q., Wang, A., In situ generation of sodium alginate/hydroxyapatite nanocomposite beads as drug-controlled release matrices. Acta Biomater 6 (2010), 445–454.
54. [54] Peng, Y., Li, J., Li, J., et al. Optimization of thermosensitive chitosan hydrogels for the sustained delivery of venlafaxine hydrochloride. Int J Pharm 441 (2013), 482–490.
55. [55] Hsiao, M.H., Larsson, M., Larsson, A., et al. Design and characterization of a novel amphiphilic chitosan nanocapsule-based thermo-gelling biogel with sustained in vivo release of the hydrophilic anti-epilepsy drug ethosuximide. J Control Release 161 (2012), 942–948.
56. [56] Ruel-Gariépy, E., Shive, M., Bichara, A., et al. A thermosensitive chitosan-based hydrogel for the local delivery of paclitaxel. Eur J Pharm Biopharm 57 (2004), 53–63.
57. [57] Berrada, M., Serreqi, A., Dabbarh, F., et al. A novel non-toxic camptothecin formulation for cancer chemotherapy. Biomaterials 26 (2005), 2115–2120.
58. [58] Li, C.Y., Ren, S.X., Dai, Y., et al. Efficacy, pharmacokinetics, and biodistribution of thermosensitive chitosan/beta-glycerophosphate hydrogel loaded with docetaxel. AAPS PharmSciTech 15 (2014), 417–424.
59. [59] Alexander, A., Ajazuddin, Khan, J., et al. Formulation and evaluation of chitosan-based long-acting injectable hydrogel for PEGylated melphalan conjugate. J Pharm Pharmacol 66 (2014), 1240–1250.
60. [60] Shamji, M.F., Hwang, P., Bullock, R.W., et al. Release and activity of anti-TNFα therapeutics from injectable chitosan preparations for local drug delivery. J Biomed Mater Res B Appl Biomater 90B (2009), 319–326.
61. [61] Chen, F., Song, S.S., Wang, H.W., et al. Injectable chitosan thermogels for sustained and localized delivery of pingyangmycin in vascular malformations. Int J Pharm 476 (2014), 232–240.
62. [62] Xing, J.Y., Qi, X.L., Jiang, Y.C., et al. Topotecan hydrochloride liposomes incorporated into thermosensitive hydrogel for sustained and efficient in situ therapy of H22 tumor in Kunming mice. Pharm Dev Technol 20 (2015), 812–819.
63. [63] Shi, J.B., Guobao, W., Chen, H.L., et al. Schiff based injectable hydrogel for in situ pH-triggered delivery of doxorubicin for breast tumor treatment. Polym Chem 5 (2014), 6180–6189.
64. [64] Bertram, U., Bernard, M.C., Haensler, J., et al. In situ gelling nasal inserts for influenza vaccine delivery. Drug Dev Ind Pharm 36 (2010), 581–593.
65. [65] Farid, R.M., Etman, M.A., Nada, A.H., Ebian, A.E.R., Formulation and in vitro evaluation of salbutamol sulphate in situ gelling nasal inserts. AAPS PharmSciTech 14 (2013), 712–718.
66. [66] Singh, R.M.P., Kumar, A., Pathak, K., Mucoadhesive in situ nasal gelling drug delivery systems for modulated drug delivery. Expert Opin Drug Deliv 10 (2013), 115–130.
67. [67] Nazar, H., Caliceti, P., Carpenter, B., et al. A once-a-day dosage form for the delivery of insulin through the nasal route: in vitro assessment and in vivo evaluation. Biomater Sci 1 (2013), 306–314.
68. [68] Wu, J., Wei, W., Wang, L.-Y., et al. A thermosensitive hydrogel based on quaternized chitosan and poly(ethylene glycol) for nasal drug delivery system. Biomaterials 28 (2007), 2220–2232.
69. [69] Nazar, H., Fatouros, D.G., van der Merwe, S.M., et al. Thermosensitive hydrogels for nasal drug delivery: the formulation and characterisation of systems based on N-trimethyl chitosan chloride. Eur J Pharm Biopharm 77 (2011), 225–232.
70. [70] Agrawal, A.K., Gupta, P.N., Khanna, A., et al. Development and characterization of in situ gel system for nasal insulin delivery. Pharmazie 65 (2010), 188–193.
71. [71] Khan, S., Patil, K., Bobade, N., et al. Formulation of intranasal mucoadhesive temperature-mediated in situ gel containing ropinirole and evaluation of brain targeting efficiency in rats. J Drug Target 18 (2010), 223–234.
72. [72] Zambito, Y., Di Colo, G., Chitosan and its derivatives as intraocular penetration enhancers. J Drug Deliv Sci Technol 20 (2010), 45–52.
73. [73] Basaran, E., Yazan, Y., Ocular application of chitosan. Expert Opin Drug Deliv 9 (2012), 701–712.
74. [74] Gupta, H., Velpandian, T., Jain, S., Ion- and pH-activated novel in-situ gel system for sustained ocular drug delivery. J Drug Target 18 (2010), 499–505.
75. [75] Chen, X.W., Li, X.R., Zhou, Y.X., et al. Chitosan-based thermosensitive hydrogel as a promising ocular drug delivery system: preparation, characterization, and in vivo evaluation. J Biomater Appl 27 (2012), 391–402.
76. [76] Valmikinathan, C.M., Mukhatyar, V.J., Jain, A., et al. Photocrosslinkable chitosan based hydrogels for neural tissue engineering. Soft Matter 8 (2012), 1964–1976.
77. [77] Du, L.N., Tong, L., Jin, Y.G., et al. A multifunctional in situ-forming hydrogel for wound healing. Wound Repair Regen 20 (2012), 904–910.
78. [78] Tran, N.Q., Joung, Y.K., Lih, E., et al. In situ forming and rutin-releasing chitosan hydrogels as injectable dressings for dermal wound healing. Biomacromolecules 12 (2011), 2872–2880.
79. [79] Li, X.Y., Chen, S., Zhang, B.J., et al. In situ injectable nano-composite hydrogel composed of curcumin, N,O-carboxymethyl chitosan and oxidized alginate for wound healing application. Int J Pharm 437 (2012), 110–119.
80. [80] Sa-Lima, H., Caridade, S.G., Mano, J.F., et al. Stimuli-responsive chitosan-starch injectable hydrogels combined with encapsulated adipose-derived stromal cells for articular cartilage regeneration. Soft Matter 6 (2010), 5184–5195.
81. [81] Niranjan, R., Koushik, C., Saravanan, S., et al. A novel injectable temperature-sensitive zinc doped chitosan/beta-glycerophosphate hydrogel for bone tissue engineering. Int J Biol Macromol 54 (2013), 24–29.
82. [82] Dessi, M., Borzacchiello, A., Mohamed, T.H.A., et al. Novel biomimetic thermosensitive beta-tricalcium phosphate/chitosan-based hydrogels for bone tissue engineering. J Biomed Mater Res A 101 (2013), 2984–2993.
83. [83] Tian, M., Yang, Z., Kuwahara, K., et al. Delivery of demineralized bone matrix powder using a thermogelling chitosan carrier. Acta Biomater 8 (2012), 753–762.
84. [84] Wang, L., Stegemann, J.P., Thermogelling chitosan and collagen composite hydrogels initiated with β-glycerophosphate for bone tissue engineering. Biomaterials 31 (2010), 3976–3985.
85. [85] Cheung, H.K., Han, T.T.Y., Marecak, D.M., et al. Composite hydrogel scaffolds incorporating decellularized adipose tissue for soft tissue engineering with adipose-derived stem cells. Biomaterials 35 (2014), 1914–1923.
86. [86] Li, X., Ma, X.X., Fan, D.D., et al. New suitable for tissue reconstruction injectable chitosan/collagen-based hydrogels. Soft Matter 8 (2012), 3781–3790.